ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
66 855,51
-0,34%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Ampio Pharmaceuticals Inc (AMPE)

  7. Ampio Pharmaceuticals Inc (AMPE) Actualités

AMPE

Ampio Pharmaceuticals (AMPE)

Ampio Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:AMPE
DateHeureSourceTitreSymboleSociété
03/04/202420h33PR Newswire (US)Ampio Pharmaceuticals Received Audit Opinion with Going Concern ExplanationAMEX:AMPEAmpio Pharmaceuticals Inc
25/03/202422h00PR Newswire (US)Ampio Announces Voluntary Delisting and SEC DeregistrationAMEX:AMPEAmpio Pharmaceuticals Inc
05/03/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:AMPEAmpio Pharmaceuticals Inc
28/02/202421h49Edgar (US Regulatory)Form 8-K - Current reportAMEX:AMPEAmpio Pharmaceuticals Inc
28/02/202421h48Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsAMEX:AMPEAmpio Pharmaceuticals Inc
28/02/202421h46Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementAMEX:AMPEAmpio Pharmaceuticals Inc
28/02/202421h45Edgar (US Regulatory)Form RW - Registration Withdrawal RequestAMEX:AMPEAmpio Pharmaceuticals Inc
14/02/202423h45PR Newswire (US)Ampio Provides Update on Results from Pre-IND Enabling StudiesAMEX:AMPEAmpio Pharmaceuticals Inc
25/01/202422h18Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:AMPEAmpio Pharmaceuticals Inc
11/01/202422h15PR Newswire (US)Ampio Provides Litigation Update - Reports Settlement in Principle of Certain Pending Legal ActionsAMEX:AMPEAmpio Pharmaceuticals Inc
21/12/202322h25Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:AMPEAmpio Pharmaceuticals Inc
14/11/202322h10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:AMPEAmpio Pharmaceuticals Inc
31/10/202314h00PR Newswire (US)Ampio Pharmaceuticals to Present at the Emerging Growth ConferenceAMEX:AMPEAmpio Pharmaceuticals Inc
05/10/202322h30PR Newswire (US)Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201AMEX:AMPEAmpio Pharmaceuticals Inc
18/09/202322h30Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933AMEX:AMPEAmpio Pharmaceuticals Inc
31/08/202312h30PR Newswire (US)Ampio Pharmaceuticals Announces Reverse Stock SplitAMEX:AMPEAmpio Pharmaceuticals Inc
15/08/202322h56Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:AMPEAmpio Pharmaceuticals Inc
13/07/202317h33Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:AMPEAmpio Pharmaceuticals Inc
14/06/202323h15Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:AMPEAmpio Pharmaceuticals Inc
09/06/202320h27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:AMPEAmpio Pharmaceuticals Inc
26/05/202322h40Edgar (US Regulatory)Current Report Filing (8-k)AMEX:AMPEAmpio Pharmaceuticals Inc
26/05/202322h40PR Newswire (US)Ampio Pharmaceuticals Announces Series D Preferred Stock Dividend to its Holders of Common StockAMEX:AMPEAmpio Pharmaceuticals Inc
08/05/202322h54Edgar (US Regulatory)Quarterly Report (10-q)AMEX:AMPEAmpio Pharmaceuticals Inc
28/04/202323h14Edgar (US Regulatory)Amended Annual Report (10-k/a)AMEX:AMPEAmpio Pharmaceuticals Inc
18/04/202312h30PR Newswire (US)AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERSAMEX:AMPEAmpio Pharmaceuticals Inc
27/03/202322h43Edgar (US Regulatory)Annual Report (10-k)AMEX:AMPEAmpio Pharmaceuticals Inc
02/02/202318h37Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:AMPEAmpio Pharmaceuticals Inc
27/12/202223h44PR Newswire (US)Ampio Pharmaceuticals Regains Compliance with NYSE American Continued Listing StandardsAMEX:AMPEAmpio Pharmaceuticals Inc
17/11/202222h53PR Newswire (US)Ampio Pharmaceuticals Announces NYSE American Removal of Trading SuspensionAMEX:AMPEAmpio Pharmaceuticals Inc
08/11/202222h30PR Newswire (US)Ampio Pharmaceuticals Announces Fifteen-to-One Reverse Stock SplitAMEX:AMPEAmpio Pharmaceuticals Inc
 Showing the most relevant articles for your search:AMEX:AMPE

Dernières Valeurs Consultées

LSE
ACMH
Absolute Capital
LATK
N1USDT
NFTify
ASX
HGO
Hillgrove Resources
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés